ACE Inhibitors and Potassium
Supplement–drug interaction evidence from the TruthStack database.
| Severity | CRITICAL |
|---|---|
| Evidence Tier | Moderate |
| Interaction Type | PHARMACODYNAMIC RISK |
| Mechanism | PHARMACODYNAMIC |
| Last Reviewed | 2026-02-16 |
Summary
ACE inhibitors reduce potassium excretion. Supplemental potassium may cause dangerous hyperkalemia. Risk is highest with CKD, diabetes, older age, or concurrent potassium-sparing diuretics. Clinician monitoring of serum potassium essential.
API Reference
GET https://api.truthstack.co/v1/check?c1=ACE%20Inhibitors&c2=Potassium
Open, unauthenticated. Returns JSON. Developer documentation
Related Interactions
What this page is and is not. TruthStack is an informational reference database that describes published pharmacological findings. It does not provide medical advice, diagnosis, or treatment recommendations. The information on this page reflects flags in our database and should not replace consultation with a qualified healthcare provider. Always discuss supplement-drug combinations with your prescriber or pharmacist.